Rejected at 10 a.m. Dec, 22, 2024 ] by Ahmed7
Author: adavis98
Related Note: 1509300283162
Rationale for change

Needs a hint that we're looking for a general state. There are several other cards that say rituximab is associated with progressive multifocal leukoencephalopathy [secondary to immunosuppression]. Need to clarify that we're not asking about this specific association

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch Monoclonal Antibody Therapy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Cellular Injury and Neoplasia: Cell Cycle Independent Drug Targets



Watch associated Bootcamp video - Pharmacology : TNF-a Inhibitors and Monoclonal Antibodies
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::18_Anticancer_monoclonal_antibodies::*Rituximab::Rituximab #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::01_Autoimmune_disease_therapy::*Rituximab #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#OME::PreClinical::Immunology #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::07_TNF_Alpha_Inhibitors_And_Monoclonal_Antibodies #AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::19_Rituximab !AK_UpdateTags::Step1decks::Lolnotacop::Drugs #AK_Step1_v12::#B&B::11_Hematology::04_Cancer_Drugs::06_Other_Cancer_Drugs #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::02_Monoclonal_Antibody_Therapy #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies